Filter the drugs by their status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Latest database update
Number of references
Remdesivir Approved by FDA Experimental Antiviral Oct/15/2020 Oct/24/2020 0
Lopinavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Oct/15/2020 Oct/16/2020 0
Favipiravir Approved for COVID-19 treatment (China, India, Russia) Used to treat other disease Antiviral Sep/25/2020 Oct/19/2020 0
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Sep/23/2020 Oct/19/2020 0
Ritonavir Recommended by China's NHC Guidelines Used to treat other disease Antiviral Sep/14/2020 Oct/05/2020 0
Oseltamivir Potential treatment - clinical evidence Used to treat other disease Antiviral Sep/02/2020 Oct/06/2020 0
Apilimod Potential treatment - pre-clinical evidence Experimental Antiviral Aug/06/2020 Aug/26/2020 0
MLN-3897 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 Jul/28/2020 0
Z LVG CHN2 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 Jul/28/2020 0
VBY-825 Potential treatment - pre-clinical evidence Experimental Antiviral Jul/24/2020 Jul/28/2020 0